UniProt ID | CASC3_HUMAN | |
---|---|---|
UniProt AC | O15234 | |
Protein Name | Protein CASC3 | |
Gene Name | CASC3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 703 | |
Subcellular Localization | Cytoplasm . Cytoplasm, perinuclear region . Nucleus . Nucleus speckle . Cytoplasm, Stress granule . Cytoplasm, Cytoplasmic ribonucleoprotein granule . Cell projection, dendrite . Shuttles between the nucleus and the cytoplasm in a XPO1/CRM1-dependent | |
Protein Description | Core component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junctions on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. The EJC marks the position of the exon-exon junction in the mature mRNA for the gene expression machinery and the core components remain bound to spliced mRNAs throughout all stages of mRNA metabolism thereby influencing downstream processes including nuclear mRNA export, subcellular mRNA localization, translation efficiency and nonsense-mediated mRNA decay (NMD). Stimulates the ATPase and RNA-helicase activities of EIF4A3. Plays a role in the stress response by participating in cytoplasmic stress granules assembly and by favoring cell recovery following stress. Component of the dendritic ribonucleoprotein particles (RNPs) in hippocampal neurons. May play a role in mRNA transport. Binds spliced mRNA in sequence-independent manner, 20-24 nucleotides upstream of mRNA exon-exon junctions. Binds poly(G) and poly(U) RNA homopolymer.. | |
Protein Sequence | MADRRRQRASQDTEDEESGASGSDSGGSPLRGGGSCSGSAGGGGSGSLPSQRGGRTGALHLRRVESGGAKSAEESECESEDGIEGDAVLSDYESAEDSEGEEGEYSEEENSKVELKSEANDAVNSSTKEEKGEEKPDTKSTVTGERQSGDGQESTEPVENKVGKKGPKHLDDDEDRKNPAYIPRKGLFFEHDLRGQTQEEEVRPKGRQRKLWKDEGRWEHDKFREDEQAPKSRQELIALYGYDIRSAHNPDDIKPRRIRKPRYGSPPQRDPNWNGERLNKSHRHQGLGGTLPPRTFINRNAAGTGRMSAPRNYSRSGGFKEGRAGFRPVEAGGQHGGRSGETVKHEISYRSRRLEQTSVRDPSPEADAPVLGSPEKEEAASEPPAAAPDAAPPPPDRPIEKKSYSRARRTRTKVGDAVKLAEEVPPPPEGLIPAPPVPETTPTPPTKTGTWEAPVDSSTSGLEQDVAQLNIAEQNWSPGQPSFLQPRELRGMPNHIHMGAGPPPQFNRMEEMGVQGGRAKRYSSQRQRPVPEPPAPPVHISIMEGHYYDPLQFQGPIYTHGDSPAPLPPQGMLVQPGMNLPHPGLHPHQTPAPLPNPGLYPPPVSMSPGQPPPQQLLAPTYFSAPGVMNFGNPSYPYAPGALPPPPPPHLYPNTQAPSQVYGGVTYYNPAQQQVQPKPSPPRRTPQPVTIKPPPPEVVSRGSS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 | Phosphorylation | DRRRQRASQDTEDEE HHHHHHHHCCCCCHH | 30.67 | 20873877 | |
13 | Phosphorylation | RQRASQDTEDEESGA HHHHHCCCCCHHHCC | 37.39 | 28985074 | |
18 | Phosphorylation | QDTEDEESGASGSDS CCCCCHHHCCCCCCC | 37.30 | 29888752 | |
21 | Phosphorylation | EDEESGASGSDSGGS CCHHHCCCCCCCCCC | 42.21 | 20873877 | |
23 | Phosphorylation | EESGASGSDSGGSPL HHHCCCCCCCCCCCC | 26.55 | 20873877 | |
25 | Phosphorylation | SGASGSDSGGSPLRG HCCCCCCCCCCCCCC | 46.91 | 20873877 | |
28 | Phosphorylation | SGSDSGGSPLRGGGS CCCCCCCCCCCCCCC | 25.04 | 25849741 | |
35 | Phosphorylation | SPLRGGGSCSGSAGG CCCCCCCCCCCCCCC | 14.37 | 29255136 | |
37 | Phosphorylation | LRGGGSCSGSAGGGG CCCCCCCCCCCCCCC | 37.16 | 29255136 | |
39 | Phosphorylation | GGGSCSGSAGGGGSG CCCCCCCCCCCCCCC | 13.88 | 29255136 | |
45 | Phosphorylation | GSAGGGGSGSLPSQR CCCCCCCCCCCCCCC | 28.60 | 23401153 | |
47 | Phosphorylation | AGGGGSGSLPSQRGG CCCCCCCCCCCCCCC | 38.51 | 29255136 | |
50 | Phosphorylation | GGSGSLPSQRGGRTG CCCCCCCCCCCCCCC | 37.49 | 29255136 | |
52 | Methylation | SGSLPSQRGGRTGAL CCCCCCCCCCCCCCE | 54.60 | - | |
55 | Methylation | LPSQRGGRTGALHLR CCCCCCCCCCCEEEE | 32.58 | - | |
66 | Phosphorylation | LHLRRVESGGAKSAE EEEEEHHCCCCCCHH | 39.40 | 25884760 | |
116 | Ubiquitination | ENSKVELKSEANDAV HHCCEEEHHHHHHHH | 32.51 | 33845483 | |
117 | Phosphorylation | NSKVELKSEANDAVN HCCEEEHHHHHHHHH | 55.34 | 29255136 | |
125 | Phosphorylation | EANDAVNSSTKEEKG HHHHHHHCCCCCCCC | 32.55 | 23401153 | |
126 | Phosphorylation | ANDAVNSSTKEEKGE HHHHHHCCCCCCCCC | 37.99 | 29255136 | |
127 | Phosphorylation | NDAVNSSTKEEKGEE HHHHHCCCCCCCCCC | 42.15 | 29255136 | |
128 | Ubiquitination | DAVNSSTKEEKGEEK HHHHCCCCCCCCCCC | 66.86 | 21906983 | |
131 | Ubiquitination | NSSTKEEKGEEKPDT HCCCCCCCCCCCCCC | 73.11 | 22817900 | |
138 | Phosphorylation | KGEEKPDTKSTVTGE CCCCCCCCCCEECCC | 35.11 | 30108239 | |
139 | Ubiquitination | GEEKPDTKSTVTGER CCCCCCCCCEECCCC | 52.05 | 32015554 | |
140 | Phosphorylation | EEKPDTKSTVTGERQ CCCCCCCCEECCCCC | 30.15 | 23927012 | |
141 | Phosphorylation | EKPDTKSTVTGERQS CCCCCCCEECCCCCC | 24.52 | 23927012 | |
143 | Phosphorylation | PDTKSTVTGERQSGD CCCCCEECCCCCCCC | 33.15 | 20201521 | |
148 | Phosphorylation | TVTGERQSGDGQEST EECCCCCCCCCCCCC | 45.10 | 29255136 | |
154 | Phosphorylation | QSGDGQESTEPVENK CCCCCCCCCCCCCCC | 30.13 | 23927012 | |
155 | Phosphorylation | SGDGQESTEPVENKV CCCCCCCCCCCCCCC | 43.48 | 23927012 | |
161 | Ubiquitination | STEPVENKVGKKGPK CCCCCCCCCCCCCCC | 38.57 | 21906983 | |
164 | Ubiquitination | PVENKVGKKGPKHLD CCCCCCCCCCCCCCC | 58.50 | 22817900 | |
165 | Ubiquitination | VENKVGKKGPKHLDD CCCCCCCCCCCCCCC | 74.62 | 22817900 | |
168 | Ubiquitination | KVGKKGPKHLDDDED CCCCCCCCCCCCCHH | 66.52 | 29967540 | |
177 | Ubiquitination | LDDDEDRKNPAYIPR CCCCHHCCCCCCCCC | 78.56 | 33845483 | |
181 | Phosphorylation | EDRKNPAYIPRKGLF HHCCCCCCCCCCCCC | 16.83 | - | |
185 | Ubiquitination | NPAYIPRKGLFFEHD CCCCCCCCCCCCCCC | 55.39 | 33845483 | |
194 | Methylation | LFFEHDLRGQTQEEE CCCCCCCCCCCCCEE | 41.03 | - | |
197 | Phosphorylation | EHDLRGQTQEEEVRP CCCCCCCCCCEECCC | 40.55 | 28555341 | |
205 | Ubiquitination | QEEEVRPKGRQRKLW CCEECCCCCHHCCHH | 57.04 | 24816145 | |
213 | Ubiquitination | GRQRKLWKDEGRWEH CHHCCHHHCCCCCCC | 57.23 | 29967540 | |
240 | Phosphorylation | RQELIALYGYDIRSA HHHHHHHHCCCHHHC | 12.48 | 27642862 | |
254 | Ubiquitination | AHNPDDIKPRRIRKP CCCCCCCCCCCCCCC | 39.19 | 24816145 | |
263 | Phosphorylation | RRIRKPRYGSPPQRD CCCCCCCCCCCCCCC | 30.40 | 30266825 | |
265 | Phosphorylation | IRKPRYGSPPQRDPN CCCCCCCCCCCCCCC | 25.19 | 23927012 | |
295 | Phosphorylation | GGTLPPRTFINRNAA CCCCCCCCCCCCCCC | 34.34 | 24505115 | |
304 | Phosphorylation | INRNAAGTGRMSAPR CCCCCCCCCCCCCCC | 19.52 | 28290473 | |
306 | Methylation | RNAAGTGRMSAPRNY CCCCCCCCCCCCCCC | 18.73 | - | |
308 | Phosphorylation | AAGTGRMSAPRNYSR CCCCCCCCCCCCCCC | 33.49 | 27251789 | |
313 | Phosphorylation | RMSAPRNYSRSGGFK CCCCCCCCCCCCCCC | 13.52 | 29759185 | |
320 | Ubiquitination | YSRSGGFKEGRAGFR CCCCCCCCCCCCCCE | 63.63 | 33845483 | |
323 | Methylation | SGGFKEGRAGFRPVE CCCCCCCCCCCEEEC | 32.40 | - | |
339 | Phosphorylation | GGQHGGRSGETVKHE CCCCCCCCCCCCCHH | 44.23 | 28555341 | |
342 | Phosphorylation | HGGRSGETVKHEISY CCCCCCCCCCHHHHH | 38.08 | 29449344 | |
344 | Ubiquitination | GRSGETVKHEISYRS CCCCCCCCHHHHHHH | 42.83 | 33845483 | |
348 | Phosphorylation | ETVKHEISYRSRRLE CCCCHHHHHHHHCCE | 16.12 | 27251275 | |
349 | Phosphorylation | TVKHEISYRSRRLEQ CCCHHHHHHHHCCEE | 20.47 | 25839225 | |
357 | Phosphorylation | RSRRLEQTSVRDPSP HHHCCEECCCCCCCC | 21.58 | 23898821 | |
358 | Phosphorylation | SRRLEQTSVRDPSPE HHCCEECCCCCCCCC | 18.17 | 19276368 | |
363 | Phosphorylation | QTSVRDPSPEADAPV ECCCCCCCCCCCCCC | 39.39 | 19664994 | |
373 | Phosphorylation | ADAPVLGSPEKEEAA CCCCCCCCHHHHHHH | 26.23 | 29255136 | |
381 | Phosphorylation | PEKEEAASEPPAAAP HHHHHHHCCCCCCCC | 58.65 | 25159151 | |
440 | Phosphorylation | PAPPVPETTPTPPTK CCCCCCCCCCCCCCC | 31.82 | 30266825 | |
441 | Phosphorylation | APPVPETTPTPPTKT CCCCCCCCCCCCCCC | 24.41 | 30266825 | |
443 | Phosphorylation | PVPETTPTPPTKTGT CCCCCCCCCCCCCCC | 39.55 | 30266825 | |
446 | Phosphorylation | ETTPTPPTKTGTWEA CCCCCCCCCCCCEEC | 42.30 | 30266825 | |
448 | Phosphorylation | TPTPPTKTGTWEAPV CCCCCCCCCCEECCC | 42.18 | 26074081 | |
450 | Phosphorylation | TPPTKTGTWEAPVDS CCCCCCCCEECCCCC | 25.93 | 26074081 | |
477 | Phosphorylation | NIAEQNWSPGQPSFL HHHHHCCCCCCCCCC | 27.05 | 16170325 | |
482 | Phosphorylation | NWSPGQPSFLQPREL CCCCCCCCCCCHHHH | 30.60 | 26074081 | |
490 | Methylation | FLQPRELRGMPNHIH CCCHHHHCCCCCCCC | 34.31 | - | |
518 | Methylation | EMGVQGGRAKRYSSQ HHCCCCCCHHCCCCC | 43.70 | - | |
667 | Phosphorylation | VYGGVTYYNPAQQQV EECCEEEECHHHCCC | 12.80 | 26074081 | |
679 | Phosphorylation | QQVQPKPSPPRRTPQ CCCCCCCCCCCCCCC | 54.37 | 26074081 | |
684 | Phosphorylation | KPSPPRRTPQPVTIK CCCCCCCCCCCCEEC | 27.79 | 20873877 | |
689 | Phosphorylation | RRTPQPVTIKPPPPE CCCCCCCEECCCCHH | 29.93 | 26074081 | |
699 | Phosphorylation | PPPPEVVSRGSS--- CCCHHHCCCCCC--- | 35.78 | 25159151 | |
702 | Phosphorylation | PEVVSRGSS------ HHHCCCCCC------ | 31.59 | 30576142 | |
703 | Phosphorylation | EVVSRGSS------- HHCCCCCC------- | 47.25 | 29496963 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CASC3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CASC3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
GRB2_HUMAN | GRB2 | physical | 21988832 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-148, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37; SER-45 AND SER-148,AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-148 AND SER-477, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-363 AND SER-373, ANDMASS SPECTROMETRY. |